Bosentan is associated with a reduction in right ventricular systolic pressure n-terminal pro-hormone b-type natriuretic peptide levels in young patients with pulmonary hypertension

HIGHLIGHTS

  • who: Lily M. Landry and collaborators from the Department of Pediatrics, Division of Pediatric Cardiology, University of Mississippi Medical Center, Jackson, USA have published the research work: Bosentan Is Associated with a Reduction in Right Ventricular Systolic Pressure N-Terminal Pro-Hormone B-Type Natriuretic Peptide Levels in Young Patients with Pulmonary Hypertension, in the Journal: (JOURNAL)
  • what: This retrospective chart review was conducted at a single-center university hospital in Jackson, Mississippi. Specific to this younger patient population, the study demonstrated a statistically significant improvement in echocardiographic and laboratory screening parameters after initiating Bosentan . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?